| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Antidrug Antibody Assay Validation: Industry Survey Results
|
Gorovits, Boris
|
|
2009
|
11 |
1 |
p. 133-138
|
article
|
| 2 |
Cannabinoids, Endocannabinoids, and Related Analogs in Inflammation
|
Burstein, Sumner H.
|
|
2009
|
11 |
1 |
p. 109-119
|
article
|
| 3 |
Delivery of Macromolecules Using Arginine-Rich Cell-Penetrating Peptides: Ways to Overcome Endosomal Entrapment
|
El-Sayed, Ayman
|
|
2008
|
11 |
1 |
p. 13-22
|
article
|
| 4 |
Drug Absorption Modeling as a Tool to Define the Strategy in Clinical Formulation Development
|
Kuentz, Martin
|
|
2009
|
11 |
1 |
p. 32
|
article
|
| 5 |
Drug Absorption Modeling as a Tool to Define the Strategy in Clinical Formulation Development
|
Kuentz, Martin
|
|
|
11 |
1 |
p. 32
|
article
|
| 6 |
Elastic Liposomal Formulation for Sustained Delivery of Colchicine: In Vitro Characterization and In Vivo Evaluation of Anti-gout Activity
|
Singh, Hardevinder Pal
|
|
2009
|
11 |
1 |
p. 54-64
|
article
|
| 7 |
Glial–Neuronal Interactions—Implications for Plasticity and Drug Addiction
|
Vijayaraghavan, Sukumar
|
|
2009
|
11 |
1 |
p. 123-132
|
article
|
| 8 |
Learning from the Viral Journey: How to Enter Cells and How to Overcome Intracellular Barriers to Reach the Nucleus
|
Mudhakir, Diky
|
|
2009
|
11 |
1 |
p. 65-77
|
article
|
| 9 |
Learning from the Viral Journey: How to Enter Cells and How to Overcome Intracellular Barriers to Reach the Nucleus
|
Mudhakir, Diky
|
|
|
11 |
1 |
p. 65-77
|
article
|
| 10 |
Model-Based Decision Making in Early Clinical Development: Minimizing the Impact of a Blood Pressure Adverse Event
|
Stroh, Mark
|
|
2009
|
11 |
1 |
p. 99-108
|
article
|
| 11 |
Modeling Subpopulations with the $MIXTURE Subroutine in NONMEM: Finding the Individual Probability of Belonging to a Subpopulation for the Use in Model Analysis and Improved Decision Making
|
Carlsson, Kristin C.
|
|
2009
|
11 |
1 |
p. 148-154
|
article
|
| 12 |
Modelling and PBPK Simulation in Drug Discovery
|
Jones, Hannah M.
|
|
2009
|
11 |
1 |
p. 155-166
|
article
|
| 13 |
Nanoparticles Containing Anti-inflammatory Agents as Chemotherapy Adjuvants II: Role of Plasma Esterases in Drug Release
|
Lu, Xiuling
|
|
2009
|
11 |
1 |
p. 120-122
|
article
|
| 14 |
Nicotine is a Selective Pharmacological Chaperone of Acetylcholine Receptor Number and Stoichiometry. Implications for Drug Discovery
|
Lester, Henry A.
|
|
2009
|
11 |
1 |
p. 167-177
|
article
|
| 15 |
Poly(ethylene glycol)-Modified Proteins: Implications for Poly(lactide-co-glycolide)-Based Microsphere Delivery
|
Pai, Sheetal S.
|
|
2009
|
11 |
1 |
p. 88-98
|
article
|
| 16 |
Predicting Pharmacokinetics of Drugs Using Physiologically Based Modeling—Application to Food Effects
|
Parrott, N.
|
|
2009
|
11 |
1 |
p. 45-53
|
article
|
| 17 |
Prediction of the Deposition of Dry Powder Aerosols
|
Mendes, Pedro J.
|
|
2009
|
11 |
1 |
p. 186-194
|
article
|
| 18 |
Protein Binding of Antimicrobials: Methods for Quantification and for Investigation of its Impact on Bacterial Killing
|
Beer, Jürgen
|
|
2008
|
11 |
1 |
p. 1-12
|
article
|
| 19 |
Recent Advances in Structure-Based Virtual Screening of G-Protein Coupled Receptors
|
Ananthan, Subramaniam
|
|
2009
|
11 |
1 |
p. 178-185
|
article
|
| 20 |
Screening for Potential Adjuvants Administered by the Pulmonary Route for Tuberculosis Vaccines
|
Wang, Chenchen
|
|
2009
|
11 |
1 |
p. 139-147
|
article
|
| 21 |
Targeted Delivery of Nucleic Acid-Based Therapeutics to the Pulmonary Circulation
|
Kuruba, Ramalinga
|
|
2008
|
11 |
1 |
p. 23-30
|
article
|
| 22 |
Targeted Delivery Systems for Oligonucleotide Therapeutics
|
Yu, Bo
|
|
2009
|
11 |
1 |
p. 195-203
|
article
|
| 23 |
Targeting Fatty Acid Amide Hydrolase (FAAH) to Treat Pain and Inflammation
|
Schlosburg, Joel E.
|
|
2009
|
11 |
1 |
p. 39-44
|
article
|
| 24 |
The Use of Clinical Utility Assessments in Early Clinical Development
|
Khan, Anis A.
|
|
2009
|
11 |
1 |
p. 33-38
|
article
|
| 25 |
Understanding the Effect of API Properties on Bioavailability Through Absorption Modeling
|
Kesisoglou, Filippos
|
|
2009
|
11 |
1 |
p. 31
|
article
|
| 26 |
Understanding the Effect of API Properties on Bioavailability Through Absorption Modeling
|
Kesisoglou, Filippos
|
|
|
11 |
1 |
p. 31
|
article
|
| 27 |
Vaginal Drug Delivery Systems for HIV Prevention
|
Rohan, Lisa Cencia
|
|
2009
|
11 |
1 |
p. 78-87
|
article
|
Journal description